Up next

Autoplay

Clinical Trial for Advanced Bile Duct Cancer

0 Views • 07/01/23
Share
Embed
administrator
administrator
Subscribers
0

Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay